Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Companion Animals

Set Alert for Companion Animals

Invoxia seeks animal health expertise for development of GPS pet tracker

French telecommunications specialist Invoxia is taking its expertise in the human GPS space into the companion animal market.

Companion Animals Equipment & Technology

Credo seeks financial backing for diagnostic trials

Credo Biomedical is looking for series B investment to further the development its lead diagnostic product.

Diagnostics Companion Animals

Ark accelerates second canine therapeutic development, eyes potential spin-out

California-based Ark Animal Health began work on establishing a companion animal therapeutics portfolio in 2014. After five years, the company is readying the launch of its resiniferatoxin candidate. Animal Pharm analyst Daniel Willis spoke to Ark president Alexis Nahama at the recent Animal Health Investment Europe forum in London about the company's future plans. 

R&D Companion Animals

Purapep eyes seed funding, series A through 2022

German pet nutritional supplement specialist Purapep has a seed funding round and series A in its sights over the next two years. 

Investments Feed & Additives

Are high costs blocking proper healthcare for companion animals?

Idaho-based pet medication supplier PetIQ believes the companion animal market in the US is set for healthy growth, despite the cost of medicine to owners proving to be a constant obstacle. Animal Pharm editor Joseph Harvey examined this dynamic and spoke to pricing specialist Graham Tatham of consultancy Simon-Kucher & Partners' animal health practice for his point-of-view.

Companion Animals Markets

Bayer stokes further Seresto growth with launch in China

Bayer Animal Health will stimulate even further growth from its Seresto flea and tick collar after introducing the product to the Chinese market.

Bayer Animal Health China

Ben Shaw: Covetrus can be as big a disruptor as IDEXX

Last month, animal health's newest billion-dollar business – Covetrus – was created and launched on the Nasdaq. Animal Pharm editor Joseph Harvey spoke to the company's president and chief executive Ben Shaw about his roots in animal health and the change Covetrus can bring to the wider veterinary sector.

Companion Animals Equipment & Technology

Pet technology experts underline barriers to success in a crowded space

At the recent Animal Health Investment Europe forum in London, Animal Pharm editor Joseph Harvey led a panel discussion on digital personalization in pet care. He spoke to three companies in this area – Fitbark, Antelliq and Felcana. Below is an excerpt of the panel discussion.

Equipment & Technology Companion Animals

Zoetis gets positive opinion for Simparica in CVS partnership

Zoetis is seeking an additional European approval for Stronghold Plus under a different brand name.

Zoetis Product Approvals

Canadian company to take swine prebiotic to other species

MSP[RS] Resistant Starch is seeking partners to take its prebiotic to new species, such as companion animals.

Feed & Additives Porcine

US pharmaceutical firm undergoes successful canine cancer study

Washington-based pharmaceutical company Vivos has reported promising results in recent trials aimed at tackling canine soft tissue sarcoma using a hydrogel treatment.

Canine Cancer

Digitalis to harness experience of vet and ex-industry expert for pet care fund

Cindy Cole is providing New York City-based investment firm Digitalis Ventures with key insights into the veterinary sector and animal health industry.

Companion Animals Investments
See All